Nsg552 exam 3 Study guides, Class notes & Summaries

Exam 1: NSG552/ NSG 552 (Latest 2023/2024) Psychopharmacology Exam| Grade A Questions and Verified Answers| 100% Correct Q: Involuntary teeth grinding associated with antipsychotics: Answer: bruxism Q: Safest and best tolerated anticonvulsant for patients taking clozapine who experience dose related seizures: Answer: topiramate Q: Less incidence of antiadrenergic, anticholinergic and antihistaminic side effects but greater E.P.S.: Answer: high potency Q: G...

Exam 3: NSG552 / NSG 552 (Latest 2024 / 2025 Update) Psychopharmacology Exam | Complete Review with Questions and Verified Answers | 100% Correct | Grade A - Wilkes Q: naltrexone class Opioid receptor antagonist Q: Naltrexone can be used for Answer: both ETOH and opioid use disorders Q: What does naltrexone do Answer: o Reduces desire/cravings o First line treatment o Will precipitate withdrawal in patients with physical opioid dependence Q: o First line treatment in maintaining abstinence after...

Exam 3: NSG552 / NSG 552 (Latest 2024 / 2025) Psychopharmacology Exam Review | Complete Guide with Verified Answers | 100% Correct - Wilkes Q: Signs vary with blood levels, from decreased reaction time, muscle incoordination, ataxia, dysarthria, to respiratory failure and coma. Answer: alcohol intoxication Q: Levels of alcohol intoxication that require no formal treatment. Answer: mild to moderate Q: Treatment includes cardiopulmonary function maintenance, thiamine, and haloperidol PRN agitation...

Exam 1: NSG552 / NSG 552 (Latest 2024 / 2025) Psychopharmacology Exam | Grade A Questions and Verified Answers | 100% Correct - Wilkes Q: Involuntary teeth grinding associated with antipsychotics: Answer: bruxism Q: Safest and best tolerated anticonvulsant for patients taking clozapine who experience dose related seizures: Answer: topiramate Q: Less incidence of antiadrenergic, anticholinergic and antihistaminic side effects but greater E.P.S.: Answer: high potency Q: Greater incidence of antiad...

naloxone MOA: Pure opioid antagonist that competes and displaces opioids at opioid receptor sites. methadone, buprenorphine, buprenorphine+naloxone Treatments for opioid use disorder. buprenorphine+naloxone Treatment for opioid use disorder with comorbid pain. opioids Inappropriate use of what substance may be due to uncontrolled pain? tablet, injectable, implant Naltrexone delivery methods. implant Form of naltrexone limited to inpatient use. bupr...

Exam 2: NSG552 / NSG 552 (Latest 2024 / 2025) Psychopharmacology Exam | Grade A Questions and Verified Answers | 100% Correct - Wilkes Q: What disorder presents as: not fixated on body shape/weight, recur- rent episodes of binge eating, no compensatory behaviors (vomiting/laxa- tives/etc), usually obese? Answer: Binge-eating disorder Q: What is the treatment for binge-eating disorder? Answer: First-line: SSRIs (escitalo- pram); Psychotherapy; Vyvanse= FDA approved/ topamx associated with weight ...

NSG552 | NSG 552 Exam 3 | Psychopharmacology Exam Study Guide 2024 Guide | Wilkes NSG552 | NSG 552 Exam 3 | Psychopharmacology Exam Study Guide 2024 Guide | Wilkes

NSG552 | NSG 552 Exam 3 | Psychopharmacology Exam 3 | Questions and Verified Answers Latest 2024 NSG552 | NSG 552 Exam 3 | Psychopharmacology Exam 3 | Questions and Verified Answers Latest 2024